Literature DB >> 12093097

Induction and activation of protein kinase C delta in hippocampus and cortex after kainic acid treatment.

Selma K Kaasinen1, Gundars Goldsteins, Leena Alhonen, Juhani Jänne, Jari Koistinaho.   

Abstract

Various isoforms of protein kinase C (PKC), especially the novel PKC subtypes delta, epsilon, and the atypical subtype PKC zeta, are involved in delayed cell death. We studied the expression and late activation of the latter PKC isoforms in comparison with classic PKC alpha, beta, and gamma in the brains of rats exposed to systemic kainate injection. The expression of PKC delta mRNA was strikingly upregulated (13-fold) in the cortex and the CA1 and CA3 hippocampal regions on 1 day after kainate administration, whereas PKC zeta mRNA was only moderately increased (about 100%) in these three brain regions on day 2 following the drug. PKC epsilon mRNA was slightly increased only in the cortex on days 2 and 6, while the mRNA levels of the classic PKC subtypes (alpha, beta, and gamma) remained unchanged or decreased after the treatment. Immunoblotting analyses revealed that the level of PKC delta protein started to increase on day 1 after kainate and was significantly elevated on day 2 in both the membrane and cytosol fractions of cortex and hippocampus. PKC epsilon protein only showed a marginal increase and the level of PKC zeta protein remained unaltered in response to the treatment. Cortical and CA1-3 pyramidal neurons displayed strong immunoreactivity for PKC delta on days 1 and 2, and microglia on days 1, 2, and 4 after the drug. The results indicate that the expression of apoptosis-associated isoforms of PKC, most notably that of delta, but to lesser extent also that of epsilon and zeta, is increased during kainate-induced neuronal death. The predominant induction of PKC delta in neurons and microglia suggests that PKC delta could be the major mediator or modulator of apoptotic and inflammatory responses to excitotoxic insults.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093097     DOI: 10.1006/exnr.2002.7919

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Identification of potentially neuroprotective genes upregulated by neurotrophin treatment of CA3 neurons in the injured brain.

Authors:  Saafan Z Malik; Shahab Motamedi; Nicolas C Royo; David LeBold; Deborah J Watson
Journal:  J Neurotrauma       Date:  2011-01-27       Impact factor: 5.269

2.  PKCδ-dependent p47phox activation mediates methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Duy-Khanh Dang; Eun-Joo Shin; Dae-Joong Kim; Hai-Quyen Tran; Ji Hoon Jeong; Choon-Gon Jang; Ole Petter Ottersen; Seung-Yeol Nah; Jau-Shyong Hong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Free Radic Biol Med       Date:  2017-12-18       Impact factor: 7.376

3.  DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo.

Authors:  Rachel Bright; Gary K Steinberg; Daria Mochly-Rosen
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

4.  Effect of rottlerin on astrocyte phenotype polarization after trimethyltin insult in the dentate gyrus of mice.

Authors:  Yeonggwang Hwang; Hyoung-Chun Kim; Eun-Joo Shin
Journal:  J Neuroinflammation       Date:  2022-06-11       Impact factor: 9.587

5.  Specific Proteomes of Hippocampal Regions CA2 and CA1 Reveal Proteins Linked to the Unique Physiology of Area CA2.

Authors:  Kyle J Gerber; Eric B Dammer; Duc M Duong; Qiudong Deng; Serena M Dudek; Nicholas T Seyfried; John R Hepler
Journal:  J Proteome Res       Date:  2019-05-14       Impact factor: 4.466

6.  Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10.

Authors:  Misti C White; Rui Gao; Weidong Xu; Santi M Mandal; Jung G Lim; Tapas K Hazra; Maki Wakamiya; Sharon F Edwards; Salmo Raskin; Hélio A G Teive; Huda Y Zoghbi; Partha S Sarkar; Tetsuo Ashizawa
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

7.  Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.

Authors:  Laura Rué; Rafael Alcalá-Vida; Graciela López-Soop; Jordi Creus-Muncunill; Jordi Alberch; Esther Pérez-Navarro
Journal:  Neuromolecular Med       Date:  2013-07-30       Impact factor: 3.843

8.  Protein kinase C-delta inhibition protects blood-brain barrier from sepsis-induced vascular damage.

Authors:  Yuan Tang; Fariborz Soroush; Shuang Sun; Elisabetta Liverani; Jordan C Langston; Qingliang Yang; Laurie E Kilpatrick; Mohammad F Kiani
Journal:  J Neuroinflammation       Date:  2018-11-06       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.